29th European Biopharma Project Program and Portfolio Management Conference
BASEL | 2025
International in-person conference filled with leading industry speakers.
key information
- Location: VIA Basel, Viaduktstrasse 31–35, 4051 Basel, Switzerland
- Part of the PPM World Tour
- April 3-4, 2025
- 9:00 - 17:30 Local Time
What to expect
In the fast-paced and ever-evolving pharmaceutical and biotech industries, effective portfolio management is key to driving innovation, optimizing resources, and ensuring long-term business success. The Project, Program, Portfolio Management Conference brings together industry leaders, decision-makers, and experts to explore cuttingedge strategies and processes that align portfolio management with organizational goals.
This conference is designed to provide participants with actionable insights and the tools necessary to elevate their portfolio management practices and make informed, data-driven decisions that enhance both short-term results and long-term growth.
Who will you meet: VP of Project & Portfolio Management, Head of Program Management, Director of Portfolio Strategy, Chief Development Officer (CDO), Senior Director of Alliance Management, VP of Business Development, Executive Director of R&D Operations, Global Head of Licensing & Partnerships, VP of Strategic Alliances, Director of External Innovation, Head of Global Partnerships, Senior Director of Clinical Portfolio Management, VP of Corporate Strategy & Development, Director of Product Lifecycle Management, VP of Strategic Operations, Senior Director of Licensing & Acquisitions.
Main takeaways
- Portfolio Strategy and Transformation: Learn how to transform your portfolio management function, from distributed to centralized models, to drive efficiency, strategic alignment, and flexibility.
- Data-Driven Decision-Making: Explore how AI and advanced tools are enhancing decision quality, optimizing portfolio prioritization, and improving R&D productivity.
- Integrating Long-Term Goals with Daily Operations: Discover how to balance short-term pressures with long-term strategic goals to ensure portfolio success.
- Managing Bias and Enhancing Decision Quality: Gain insights into the frameworks and methodologies that can help mitigate bias and improve transparency in portfolio decisions.
Everything you need to know about this event in one spot.
Check out our event overview and agenda and discover Portfolio Management Conference Basel 2025.
Event Partners
GOLD Sponsor
Planisware is a leading provider of project portfolio management (PPM) solutions. Our mission is to help organizations strategize, plan, and deliver their projects, portfolios, programs, and products more effectively.
Our solutions, Planisware Enterprise and Planisware Orchestra, are trusted worldwide, supported by a strong partner network and 12 offices across the globe. In 2023, we achieved 19% growth, but what we are most proud of is our 98% customer retention rate—a rare achievement in today’s competitive landscape.
In 2024, Gartner® recognized Planisware as a Leader in the Magic Quadrant™ for Adaptive Project Management & Reporting, reaffirming our commitment to innovation and excellence.
Silver Sponsor
Platflow is a comprehensive suite of cloud-based and on-premise software solutions (PLM, PPM, G2M) designed to empower enterprises in Life Science industries, including Pharma, Crop Science, Cosmetics, Biotech, Medical Devices, and CRO/CMO. By streamlining your product development processes, Platflow helps enhance product quality while accelerating innovation and reducing time-to-market. With its intuitive interface and easy-to-use features, Platflow requires minimal training, allowing teams to focus on their core competencies.
Silver Sponsor
Blue Matter Consulting is a strategic consulting firm serving the life sciences industry. Its diverse client base includes more than 250 companies, ranging from start-ups to leading global biopharma companies. The firm helps clients develop strategy and maximize value at the product, portfolio, and organizational levels.
To deliver strategic projects, the firm integrates expertise across critical industry functions (including Business Development, Market Access, Marketing and Sales, and Medical Affairs) with comprehensive capabilities in primary research and data analytics. The firm specializes in corporate and portfolio strategy, as well as commercial strategy for pre-launch and launch-stage therapies. However, it also assists clients with in-line (marketed) products.
Blue Matter performs work in a range of therapeutic areas but offers in-depth expertise in complex markets such as oncology, CNS, and rare diseases. The firm works with the full range of product types, encompassing small molecules and large molecules, including cell and gene therapies.
Silver Sponsor
Global Partners Training (GPT) was founded in 1990 and is a pioneer in Validated Behavior Change training programs. With a deep training portfolio of core skills aimed at front-line, supervisory, and leadership roles and a global facilitation team of passionate former industry executives, GPT drives lasting and measurable behavioral change at individual and enterprise scale. Regular work with top regional and global companies in diverse industries, such as MedTech, Semiconductor Equipment, Pharmaceuticals and Telecom gives GPT a unique ability to connect with your people on their turf, sharpen their core job and “human” skills, and deliver measurable business value.
Strategic Partner
Captario is a software company catering to the pharmaceutical industry. Captario develops SUM® – Strategic Uncertainty Management, a cloud-based modeling & simulation software further empowered by AI and Machine Learning. It enables project and portfolio teams to base strategic decisions on a rich understanding of practically all possible futures.
Associate Partner
Tillotts Pharma AG is a Swiss-based, well-established and fast-growing pharmaceutical specialty company with global reach and M&A expertise. It has sales of around a third a billion USD and a sustainable double-digit average annual sales growth. Tillotts with its around 400 employees is part of the Japanese Zeria Group.
Tillotts is successfully marketing own, acquired and/or in-licensed specialty products in two core disciplines of gastrointestinal and infectious diseases.
This continued success and strong track record in partnering is based on coverage of 24 key European markets with own affiliates, a proven network of dedicated commercial partners in 40+ markets, lean processes and strong teams for the integration of new products, combined with extensive expertise in market access and regulatory matters in- and outside Europe.
Tillotts is particularly interested in acquiring and/or in-licensing late-stage pharmaceutical products treating gastrointestinal and infectious diseases and additionally specialty hospital products.
Industry Pioneers Attending From
Event Speakers
Alex Rodriguez
Director International Medical Affairs Immunology - Dermatology/Allergy
Novartis
Anastasiia Karnaukhova
Head of Global Program Management N&I, Fertility, CM&E & Global Health, Healthcare | Global R&D Strategy, Portfolio & Hubs
Merck
Bernhard Glombitza
VP & Head Clinical Operations & Customer Engagement EMEA & LATAM
Bayer
Carole Abel
VP, Head of PMO
Mindmed
Cornelia Lassen
Head of Portfolio Management
Dr. Reddy's Laboratories
Corinne Esperet
Global Project & Portfolio Management Head
Sanofi
Deepak Veeraraghavan
Partner
Blue Matter
Eliza Gabryjelczyk
Director, Evidence Program Management
Astrazeneca
Fabrice Guerrier
Executive Principal
Global Partners Training
Fabrizio Battaglia
Executive Partner
Global Partners Training
Testimonials
